Central Nervous System Depression

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Depression Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Depression Projects
--AstraZeneca Plc
--Amarin Corporation plc
--Biovail Corporation
--Barr Pharmaceuticals Inc
--Caraco Pharmaceutical Laboratories Ltd
--Bristol-Myers Squibb Company
--Eli Lilly & Co
--Dov Pharmaceutical Inc
--Forest Laboratories Inc
--Fabre-Kramer Pharmaceuticals, Inc.
--H.Lundbeck AS
--GlaxoSmithKline plc
--Ono Pharmaceutical Co., Ltd.
--NeuroSearch A/S
--Sanofi-Aventis
--Pfizer Inc
--Takeda Pharmaceutical Company Limited
--Shionogi & Co., Ltd.
--Zydus Cadila Healthcare Limited
--Wyeth

--Top Companies in early stage Depression Projects
--Addex Pharmaceuticals SA
--Abiogen Pharma S.p.A.
--CeNeRx BioPharma
--AstraZeneca Plc
--CyDex Pharmaceuticals, Inc.
--Chemgenex Pharmaceuticals Ltd
--Evotec AG
--Dnaprint Genomics Inc
--Johnson & Johnson
--GlaxoSmithKline plc
--Krenitsky Pharmaceuticals Inc.
--Karo Bio AB
--Roche Holdings Ltd
--Pherin Pharmaceuticals, Inc.
--Sepracor Inc
--Sanofi-Aventis
--Targacept Inc
--Taisho Pharmaceutical Co., Ltd.
--Wyeth
--Winston Laboratories, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View